GlassScriptPhysician profile
Jody Giannotti
$3,439.92
in general payments reported to CMS, 2019-2025
17 companies · $555 in 2025
The $555 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $343 · 2022: $1,314 · 2023: $714 · 2024: $514 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,782.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $494.88 | 2021-2022 | |
| Genzyme Corporation | $395.37 | 2022-2024 | |
| Janssen Biotech, INC. | $385.43 | 2022-2025 | Rybrevant, Akeega, Erleada |
| Beigene USA, INC. | $347.48 | 2022-2024 | Brukinsa |
| Seagen INC. | $266.84 | 2021-2022 | |
| Daiichi Sankyo INC. | $235.37 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $218.02 | 2022-2023 | |
| Syndax Pharmaceuticals, INC. | $209.72 | 2025 | Revuforj |
| Janssen Scientific Affairs, LLC | $145.03 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $124.61 | 2022 | |
| Kite Pharma, INC. | $122.06 | 2022 | |
| Abbvie INC. | $118.11 | 2023 | |
| Deciphera Pharmaceuticals INC. | $90.33 | 2022 | |
| Jazz Pharmaceuticals INC. | $78.12 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $70.73 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $69.30 | 2025 | |
| Novocure INC. | $68.52 | 2024 | Optune Lua (Novottf-200t) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Giannotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.